Cargando…

Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer

Human serum albumin (HSA)-based drug delivery systems are promising for improving delivery efficiency, anticancer activity and selectivity of anticancer agents. To rationally guide to design HSA carrier for anticancer metal agent, we built a breast mouse model on developing anti-cancer copper (Cu) p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gou, Yi, Zhang, Yao, Qi, Jinxu, Chen, Shifang, Zhou, Zuping, Wu, Xiaoyang, Liang, Hong, Yang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341853/ https://www.ncbi.nlm.nih.gov/pubmed/27564255 http://dx.doi.org/10.18632/oncotarget.11465

Ejemplares similares

Warfarin and Flavonoids Do Not Share the Same Binding Region in Binding to the IIA Subdomain of Human Serum Albumin
por: Rimac, Hrvoje, et al.
Publicado: (2017)

Human serum albumin as a copper source for anticancer thiosemicarbazones
por: Schaier, Martin, et al.
Publicado: (2023)

Inhaled Anesthetics Promote Albumin Dimerization through Reciprocal Exchange of Subdomains
por: Pieters, Benjamin J., et al.
Publicado: (2010)

The Influence of Oxidative Stress on Serum Albumin Structure as a Carrier of Selected Diazaphenothiazine with Potential Anticancer Activity
por: Maciążek-Jurczyk, Małgorzata, et al.
Publicado: (2021)

Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin
por: Kawai, Akito, et al.
Publicado: (2022)

Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug
por: Mashreghi, Maral, et al.
Publicado: (2023)

A Chalcone-Based Potential Therapeutic Small Molecule That Binds to Subdomain IIA in HSA Precisely Controls the Rotamerization of Trp-214
por: Kumar, Himank, et al.
Publicado: (2018)

Double-Site Binding and Anti-/Pro-oxidation of Luteolin on Bovine Serum Albumin Mediated by Copper(II) Coordination
por: Song, Meng-Ting, et al.
Publicado: (2022)

Interaction of human serum albumin with anticancer agents in vitro.
por: Takahashi, I., et al.
Publicado: (1980)

Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy
por: Sasaki, Koichi, et al.
Publicado: (2019)

Interaction of the Anticancer Plant Alkaloid Sanguinarine with Bovine Serum Albumin
por: Hossain, Maidul, et al.
Publicado: (2011)

Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

On domain decomposition and subdomain iteration
por: Bjørhus, M
Publicado: (1995)

The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer
por: Zhang, Can, et al.
Publicado: (2019)

Potent anticancer activity of cystine-based dipeptides and their interaction with serum albumins
por: Banerji, Biswadip, et al.
Publicado: (2013)

Theoretical aspects of interaction of the anticancer drug cytarabine with human serum albumin
por: Amirinasab, Maryam, et al.
Publicado: (2023)

Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review
por: Teixeira, Sofia, et al.
Publicado: (2022)

Protein-templated copper nanoclusters for fluorimetric determination of human serum albumin
por: Lettieri, Mariagrazia, et al.
Publicado: (2021)

Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer
por: An, Qiang, et al.
Publicado: (2020)

Tanshinone IIA reduces secretion of pro-angiogenic factors and inhibits angiogenesis in human colorectal cancer
por: Zhou, Lihong, et al.
Publicado: (2020)

Exploring subdomain variation in biomedical language
por: Lippincott, Thomas, et al.
Publicado: (2011)

Distinctive Subdomains in the Resorbing Surface of Osteoclasts
por: Szewczyk, Kinga A., et al.
Publicado: (2013)

Kinesin motility is driven by subdomain dynamics
por: Hwang, Wonmuk, et al.
Publicado: (2017)

Pretreatment C‐reactive protein/albumin ratio is associated with poor survival in patients with stage IB‐IIA cervical cancer
por: Zhang, Weiwei, et al.
Publicado: (2017)

Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer
por: Wang, Shan, et al.
Publicado: (2023)

Design and Synthesis of Novel Peptides to Protect Ferulic Acid against Ultraviolet Radiation Based on Domain Site IIA of Bovine Serum Albumin
por: Wu, Yinghan, et al.
Publicado: (2021)

EPI64 regulates microvillar subdomains and structure
por: Hanono, Abraham, et al.
Publicado: (2006)

Semi-discrete subdomain iteration for hyperbolic systems
por: Bjørhus, M
Publicado: (1995)

Cooperative Assembly of Hsp70 Subdomain Clusters
por: Wright, Maya A., et al.
Publicado: (2018)

Potential of Copper and Copper Compounds for Anticancer Applications
por: Ji, Peng, et al.
Publicado: (2023)

Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy
por: Ge, Liang, et al.
Publicado: (2018)

Effects of Zinc supplementation on serum copper to Zinc and CRP to albumin ratios in hemodialysis patients
por: Hajji, Marwa, et al.
Publicado: (2021)

Synthesis and characterization of bovine serum albumin-coated copper sulfide nanoparticles as curcumin nanocarriers
por: Mohammadi, Ali, et al.
Publicado: (2023)

Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model
por: Noorani, Lubna, et al.
Publicado: (2015)

Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications
por: Fratoddi, Ilaria, et al.
Publicado: (2019)

Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear
por: Yu, Zhan, et al.
Publicado: (2014)

Interaction between human serum albumin and cholesterol-grafted polyglutamate as the potential carriers of protein drugs
por: Lyu, Xiangxue, et al.
Publicado: (2019)

Human serum albumin as a clinically accepted cell carrier solution for skin regenerative application
por: Shahin, Hady, et al.
Publicado: (2020)

Study of Interactions of an Anticancer Drug Neratinib With Bovine Serum Albumin: Spectroscopic and Molecular Docking Approach
por: Wani, Tanveer A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v0ta9enjj9r73vjk8bog1ghina